Literature DB >> 10712317

Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease.

E C Creutzberg1, A M Schols, C A Weling-Scheepers, W A Buurman, E F Wouters.   

Abstract

Nutritional support can increase body weight and physiologic function in COPD, but there are some patients who do not respond to nutritional therapy. The aim of this prospective study was to describe the nonresponse to 8 wk of oral nutritional supplementation therapy (500 to 750 kcal/d extra), implemented in an inpatient pulmonary rehabilitation program, with respect to lung function, body composition, energy balance, and systemic inflammatory profile in 24 (16 male) depleted patients with COPD. On the basis of the weight change after 8 wk, patients were divided into three groups (Group 1: weight gain < 2% of baseline body weight, n = 5; Group 2: weight gain 2 to 5%, n = 9; Group 3: weight gain >/= 5%, n = 10). Although no differences were seen in lung function and body composition, Group 1 was characterized by older age, a lower baseline dietary intake/resting energy expenditure (REE) ratio, and a greater number of users of continuous supplemental oxygen when compared with Group 3. In addition, Group 1 exhibited higher baseline concentrations of fasting glucose and LPS-binding protein than did Groups 2 and 3. The concentrations of the soluble TNF- receptors 55 and 75 were elevated in Groups 1 and 2 when compared with Group 3. Furthermore, a significant, inverse correlation coefficient between baseline dietary intake and soluble intercellular adhesion molecule was revealed (r = -0.50, p = 0.016). On linear regression analysis, age, baseline intake/REE ratio, sTNF-receptor 55, and extracellular/intracellular water (ECW/ICW) ratio were selected as independent, significant parameters contributing to a total explained variation of 78% in weight change after nutritional therapy. In conclusion, nonresponse to nutritional therapy in COPD is associated with ageing, relative anorexia, and an elevated systemic inflammatory response. Further research is needed to investigate whether these factors contribute to eventual disturbances in intermediary metabolism as reflected by the increased glucose concentration and ECW/ICW ratio.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712317     DOI: 10.1164/ajrccm.161.3.9808075

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  24 in total

1.  Sarcopaenia in chronic obstructive pulmonary disease.

Authors:  Michael C Steiner
Journal:  Thorax       Date:  2007-02       Impact factor: 9.139

2.  Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease.

Authors:  W D-C Man; N S Hopkinson; F Harraf; D Nikoletou; M I Polkey; J Moxham
Journal:  Thorax       Date:  2005-05-27       Impact factor: 9.139

3.  Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease.

Authors:  R Broekhuizen; E F M Wouters; E C Creutzberg; C A P M Weling-Scheepers; A M W J Schols
Journal:  Thorax       Date:  2005-05       Impact factor: 9.139

Review 4.  Can muscle protein metabolism be specifically targeted by nutritional support and exercise training in chronic obstructive pulmonary disease?

Authors:  Ramzi Lakhdar; Roberto A Rabinovich
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 5.  Comorbidities in chronic obstructive pulmonary disease.

Authors:  Wissam M Chatila; Byron M Thomashow; Omar A Minai; Gerard J Criner; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 6.  Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives.

Authors:  Ruzena Tkacova
Journal:  Mediators Inflamm       Date:  2010-04-20       Impact factor: 4.711

Review 7.  Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients.

Authors:  Roberto A Rabinovich; Jordi Vilaró
Journal:  Curr Opin Pulm Med       Date:  2010-03       Impact factor: 3.155

8.  Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  M C Steiner; R L Barton; S J Singh; M D L Morgan
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

9.  Effect of octanoic acid-rich formula on plasma ghrelin levels in cachectic patients with chronic respiratory disease.

Authors:  Jun-Ichi Ashitani; Nobuhiro Matsumoto; Masamitsu Nakazato
Journal:  Nutr J       Date:  2009-06-16       Impact factor: 3.271

Review 10.  Targeted treatment in COPD: a multi-system approach for a multi-system disease.

Authors:  David Anderson; William Macnee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.